☰

Anish Suri, Ph.D. - Publications

Affiliations: 
2002 Washington University, Saint Louis, St. Louis, MO 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Seidel RD, Merazga Z, Thapa DR, Soriano J, Spaulding E, Vakkasoglu AS, Ruthardt P, Bautista W, Quayle SN, Kiener PA, Low S, Ross JF, Cemerski S, Suri A, Almo SC, et al. Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells. Scientific Reports. 11: 19220. PMID 34584159 DOI: 10.1038/s41598-021-98716-z  0.448
2021 Lim JJ, Jones CM, Loh TJ, Ting YT, Zareie P, Loh KL, Felix NJ, Suri A, McKinnon M, Stevenaert F, Sharma RK, Klareskog L, Malmström V, Baker DG, Purcell AW, et al. The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR. Science Immunology. 6. PMID 33863750 DOI: 10.1126/sciimmunol.abe0896  0.401
2020 Thapa D, Histed A, Soriano J, Witt L, Merazga Z, Girgis N, Moreta M, Diaz F, Zhao F, Kemp M, Ruthardt P, Suri A, Quayle S, Ross J, Cemerski S. Abstract 6699: CUE-102 Immuno-STATs for selective targeting and expansion of WT1-specific T cells for the treatment of HLA-A02+and/or HLA-A24+patients with WT1+malignancies Immunology. 80: 6699-6699. DOI: 10.1158/1538-7445.Am2020-6699  0.495
2018 Ting YT, Petersen J, Ramarathinam SH, Scally SW, Loh KL, Thomas R, Suri A, Baker DG, Purcell AW, Reid HH, Rossjohn J. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in Rheumatoid Arthritis. The Journal of Biological Chemistry. PMID 29317506 DOI: 10.1074/jbc.RA117.001013  0.387
2016 Yamniuk AP, Suri A, Krystek SR, Tamura J, Ramamurthy V, Kuhn R, Carroll K, Fleener C, Ryseck R, Cheng L, An Y, Drew P, Grant S, Suchard SJ, Nadler SG, et al. Functional antagonism of human CD40 achieved by targeting a unique species-specific epitope. Journal of Molecular Biology. PMID 27216500 DOI: 10.1016/J.Jmb.2016.05.014  0.323
2014 Xie JH, Yamniuk AP, Borowski V, Kuhn R, Susulic V, Rex-Rabe S, Yang X, Zhou X, Zhang Y, Gillooly K, Brosius R, Ravishankar R, Waggie K, Mink K, Price L, ... ... Suri A, et al. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases. Journal of Immunology (Baltimore, Md. : 1950). 192: 4083-92. PMID 24670803 DOI: 10.4049/Jimmunol.1303239  0.316
2012 Suri A, Levisetti M. Animal models for type 1 diabetes Methods in Pharmacology and Toxicology. 303-318. DOI: 10.1007/978-1-62703-095-3_19  0.359
2010 Felix NJ, Suri A, Salter-Cid L, Nadler SG, Gujrathi S, Corbo M, Aranda R. Targeting lymphocyte co-stimulation: from bench to bedside. Autoimmunity. 43: 514-25. PMID 20429850 DOI: 10.3109/08916931003674741  0.405
2010 Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER, Murphy TL, Murphy KM. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nature Immunology. 11: 129-35. PMID 20037585 DOI: 10.1038/Ni.1835  0.567
2009 Markiewicz MA, Wise EL, Buchwald ZS, Cheney EE, Hansen TH, Suri A, Cemerski S, Allen PM, Shaw AS. IL-12 enhances CTL synapse formation and induces self-reactivity. Journal of Immunology (Baltimore, Md. : 1950). 182: 1351-61. PMID 19155481 DOI: 10.4049/Jimmunol.182.3.1351  0.369
2008 Calderon B, Suri A, Pan XO, Mills JC, Unanue ER. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. Journal of Immunology (Baltimore, Md. : 1950). 181: 6964-74. PMID 18981116 DOI: 10.4049/Jimmunol.181.10.6964  0.595
2008 Calderon B, Suri A, Miller MJ, Unanue ER. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proceedings of the National Academy of Sciences of the United States of America. 105: 6121-6. PMID 18427107 DOI: 10.1073/Pnas.0801973105  0.625
2008 Levisetti MG, Lewis DM, Suri A, Unanue ER. Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes. 57: 1852-60. PMID 18398138 DOI: 10.2337/Db08-0068  0.709
2008 Suri A, Walters JJ, Rohrs HW, Gross ML, Unanue ER. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. Journal of Immunology (Baltimore, Md. : 1950). 180: 3849-56. PMID 18322192 DOI: 10.4049/Jimmunol.180.6.3849  0.716
2008 Suri A, Levisetti MG, Unanue ER. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Current Opinion in Immunology. 20: 105-10. PMID 18082388 DOI: 10.1016/J.Coi.2007.10.007  0.712
2008 Suri A, Szallasi A. The emerging role of TRPV1 in diabetes and obesity. Trends in Pharmacological Sciences. 29: 29-36. PMID 18055025 DOI: 10.1016/J.Tips.2007.10.016  0.347
2007 Levisetti MG, Suri A, Petzold SJ, Unanue ER. The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. Journal of Immunology (Baltimore, Md. : 1950). 178: 6051-7. PMID 17475829 DOI: 10.4049/Jimmunol.178.10.6051  0.642
2007 Felix NJ, Donermeyer DL, Horvath S, Walters JJ, Gross ML, Suri A, Allen PM. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nature Immunology. 8: 388-97. PMID 17322886 DOI: 10.1038/Ni1446  0.508
2007 Chang KY, Suri A, Unanue ER. Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm. Proteomics. 7: 367-77. PMID 17211830 DOI: 10.1002/Pmic.200600584  0.711
2006 Calderon B, Suri A, Unanue ER. In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model. The American Journal of Pathology. 169: 2137-47. PMID 17148676 DOI: 10.2353/Ajpath.2006.060539  0.594
2006 Suri A, Calderon B, Esparza TJ, Frederick K, Bittner P, Unanue ER. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science (New York, N.Y.). 311: 1778-80. PMID 16556846 DOI: 10.1126/Science.1123500  0.555
2006 Suri A, Walters JJ, Levisetti MG, Gross ML, Unanue ER. Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. European Journal of Immunology. 36: 544-57. PMID 16479539 DOI: 10.1002/Eji.200526235  0.663
2006 Felix NJ, Suri A, Walters JJ, Horvath S, Gross ML, Allen PM. I-Ep-bound self-peptides: identification, characterization, and role in alloreactivity. Journal of Immunology (Baltimore, Md. : 1950). 176: 1062-71. PMID 16393994 DOI: 10.4049/Jimmunol.176.2.1062  0.555
2006 Suri A, Lovitch SB, Unanue ER. The wide diversity and complexity of peptides bound to class II MHC molecules. Current Opinion in Immunology. 18: 70-7. PMID 16316750 DOI: 10.1016/J.Coi.2005.11.002  0.762
2006 Suri A, Unanue ER. Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice Science. 314: 1243d-1243d. DOI: 10.1126/Science.1129917  0.522
2006 Levisetti M, Suri A, Petzold S, Unanue E. Su.32. Insulin-Specific T-Cells in Nod Mice: Evidence for Recognition of the Dominant Epitope in Two Distinct Binding Registers Clinical Immunology. 119: S170. DOI: 10.1016/J.Clim.2006.04.459  0.563
2005 Suri A, Unanue ER. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection. Advances in Immunology. 88: 235-65. PMID 16227092 DOI: 10.1016/S0065-2776(05)88007-1  0.682
2005 Unanue E, Byersdorfer C, Carrero J, Levisetti M, Lovitch S, Pu Z, Suri A. Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common? Immunologic Research. 32: 267-92. PMID 16106079 DOI: 10.1385/Ir:32:1-3:267  0.761
2005 Suri A, Walters JJ, Gross ML, Unanue ER. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. The Journal of Clinical Investigation. 115: 2268-76. PMID 16075062 DOI: 10.1172/Jci25350  0.675
2004 Levisetti MG, Suri A, Frederick K, Unanue ER. Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes. 53: 3115-9. PMID 15561941 DOI: 10.2337/Diabetes.53.12.3115  0.561
2004 Suri A, Shimizu J, Katz JD, Sakaguchi S, Unanue ER, Kanagawa O. Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. European Journal of Immunology. 34: 447-54. PMID 14768049 DOI: 10.1002/Eji.200324599  0.59
2003 Levisetti MG, Suri A, Vidavsky I, Gross ML, Kanagawa O, Unanue ER. Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice. International Immunology. 15: 1473-83. PMID 14645156 DOI: 10.1093/Intimm/Dxg143  0.632
2003 Suri A, Walters JJ, Kanagawa O, Gross ML, Unanue ER. Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition. Proceedings of the National Academy of Sciences of the United States of America. 100: 5330-5. PMID 12682304 DOI: 10.1073/Pnas.0330859100  0.672
2002 Suri A, Vidavsky I, van der Drift K, Kanagawa O, Gross ML, Unanue ER. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. Journal of Immunology (Baltimore, Md. : 1950). 168: 1235-43. PMID 11801660 DOI: 10.4049/Jimmunol.168.3.1235  0.641
2000 Latek RR, Suri A, Petzold SJ, Nelson CA, Kanagawa O, Unanue ER, Fremont DH. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity. 12: 699-710. PMID 10894169 DOI: 10.1016/S1074-7613(00)80220-4  0.764
1999 Suri A, Katz JD. Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunological Reviews. 169: 55-65. PMID 10450508 DOI: 10.1111/J.1600-065X.1999.Tb01306.X  0.484
Show low-probability matches.